MEDTOX Scientific Inc. (MTOX) Reports In-Line Q4 EPS
- Fed Drops 'Considerable Time', Says Can be 'Patient' on Rates
- Wall Street Looks to Profit from New and Improved Cuba Relations (CUBA) (RCL) (CCL)
- Unusual 11 Mid-Day Movers 12/17: (ASPX) (VOLC) (DRIV) Higher; (NVGN) (BEAV) (RT) Lower
- Philips N.V. (PHG) to Acquire Volcano (VOLC) in $1B Deal
- Morgan Stanley Sees Major Server Cycle in 2015, Upgrades IT Hardware Sector (HPQ) (STX) (WDC) (QLGC)
MEDTOX Scientific Inc. (NASDAQ: MTOX) reported Q4 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $25 million versus the consensus estimate of $24.49 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intelligent Systems Corp. (INS) Intends to Explore Strategic Initiatives, Parties Interested in Major Subsidiaries
- Darden Restaurants (DRI) Tops Q2 EPS by 1c, Boosts Low End of FY15 EPS Guidance
- Whirlpool (WHR) Gains on Inestor Day Presentation; Sees EPS Doubling by FY18